Cerebral infarction in a patient with inhibitor-positive hemophilia B treated with plasma-derived factor VIIa and factor X mixture

Ann Hematol. 2024 Jun;103(6):2161-2162. doi: 10.1007/s00277-024-05729-5. Epub 2024 Apr 13.
No abstract available

Publication types

  • Letter
  • Case Reports

MeSH terms

  • Cerebral Infarction* / blood
  • Cerebral Infarction* / etiology
  • Factor VIIa* / therapeutic use
  • Factor X*
  • Hemophilia B* / blood
  • Hemophilia B* / complications
  • Hemophilia B* / drug therapy
  • Humans
  • Male
  • Middle Aged

Substances

  • Factor VIIa
  • Factor X